Respiratory Syncytial Virus

RSV is a common virus causing serious breathing infections in infants and children; early diagnosis and pediatric care at Liv Hospital help prevent complications.

Liv Hospital provides early diagnosis and pediatric care for Respiratory Syncytial Virus Infection (RSV) to help protect infants from severe respiratory illness.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Respiratory Syncytial Virus Overview and Definition

What Is RSV and Why Is It Dangerous for Infants?

Respiratory Syncytial Virus (RSV) is a highly contagious, common respiratory virus that infects the lungs and breathing passages. While it typically causes mild, cold like symptoms in healthy adults and older children, it is a leading cause of serious lower respiratory tract infections such as Bronchiolitis and Pneumonia in infants and the elderly. In fact, RSV is recognized globally as the most frequent cause of hospitalization in children under the age of one.

The virus gets its name from its ability to cause infected cells to fuse together, forming large, multi nucleated structures called “syncytia.” This process disrupts the delicate lining of the airways, leading to inflammation and the accumulation of thick mucus.
For most people, RSV is an inevitable part of childhood, with nearly all children having been infected at least once by their second birthday. However, for premature infants or those with underlying heart and lung conditions, RSV is a significant medical threat that requires vigilant monitoring.

The Seasonality of RSV

RSV is a seasonal virus, typically peaking during the late fall, winter, and early spring months in temperate climates. It spreads through respiratory droplets when an infected person coughs or sneezes, and it can survive for several hours on hard surfaces like doorknobs, toys, and countertops.
This environmental resilience makes it particularly difficult to control in daycare centers and schools.

Symptoms and Conditions

How Does RSV Progress in the Body?

The hallmark of RSV is its progression. It usually starts as a simple upper respiratory infection with a runny nose and decreased appetite. However, in vulnerable patients, the virus “descends” into the lower airways. This leads to Bronchiolitis, characterized by wheezing, rapid breathing, and a “caving in” of the chest.

Diagnosis and Evaluation

How Is RSV Diagnosed?

Because RSV symptoms overlap with the flu, COVID-19, and the common cold, laboratory confirmation is often necessary for hospitalized patients.
Doctors use rapid antigen tests or highly sensitive PCR (Polymerase Chain Reaction) swabs taken from the nose to identify the virus. Clinical evaluation also includes checking oxygen levels and chest X-rays.

Treatment and Care

How Is RSV Treated?

There is currently no specific “cure” or widely available antiviral medication that kills RSV in children.
Therefore, treatment is “supportive,” meaning the focus is on keeping the patient hydrated, clearing the airway of mucus, and providing supplemental oxygen if needed. Most healthy children recover at home, but those with severe breathing difficulties require specialized hospital care.

Growth and Prevention

How Can RSV Be Prevented?

Prevention has entered a new era with the development of RSV vaccines and monoclonal antibody treatments (like Nirsevimab).
For high-risk infants, these “passive immunizations” provide a critical shield during the peak season. Long-term recovery involves monitoring for “post-RSV wheezing,” which can sometimes persist for years.

The Impact on Small Airways

Infants are uniquely vulnerable to RSV because their airways are naturally very small and narrow.
When the virus causes inflammation and mucus buildup, these tiny tubes (bronchioles) can become completely blocked.
This is why “wheezing” the sound of air whistling through a narrowed passage—is so common in infant RSV cases.

Reinfection is Common

Unlike some viruses that provide lifelong immunity after one infection (like measles), the human body does not develop permanent immunity to RSV.
It is possible to be infected multiple times throughout life, though subsequent infections are usually much milder than the first one.

High-Risk Groups

While RSV can affect anyone, four groups are at the highest risk for severe disease:

Premature infants (born before 35 weeks).
Infants under 6 months of age.
Children with congenital heart disease or chronic lung disease.
Children with weakened immune systems due to medical treatments.

Transmission and Hygiene

RSV is frequently brought into the home by older school-aged children who have mild symptoms.
Because the virus lives on surfaces, handwashing is the single most effective way to prevent transmission. A person is usually contagious for 3 to 8 days, but infants with weakened immune systems can spread the virus for up to 4 weeks.

A Coordinated Pediatric Response

At Liv Hospital, our approach to RSV is multidisciplinary. We combine the expertise of pediatricians, respiratory therapists, and infectious disease specialists to manage the virus.
From early screening in our emergency department to advanced respiratory support in our pediatric wards, we focus on minimizing the stress of the infection on the child’s developing body.

How Does Liv Hospital Treat RSV in Children?

At Liv Hospital, our Pediatric Pulmonology and Neonatal Intensive Care teams specialize in managing RSV (Respiratory Syncytial Virus).
We use high flow nasal cannula (HFNC) therapy to help infants breathe more comfortably, often avoiding invasive ventilation. Our diagnostic laboratory provides rapid PCR testing to quickly identify the virus.
With advanced monitoring and a sterile care environment, Liv Hospital supports children and their families safely throughout the RSV season.